Introduction. Women with epilepsy have increased risk of complications in pregnancy with consequences for the mother and child. There are no studies on the influence of parity on complications in women with epilepsy. Material and methods. This was a population-based cohort study of all first and second births in the Medical Birth Registry of Norway 1999-2013. Risks were estimated and complication rates were compared in distinct women with epilepsy treatment categories. Outcomes were any hypertensive disorder, bleeding in pregnancy, induction of labor, cesarean section, postpartum hemorrhage and preterm birth. Results. We examined 361 588 women, of whom 211 248 had a second birth and 1074 (0.5%) of these had a diagnosis of epilepsy in both births. Of these, 406 used antiepileptic drugs in both pregnancies with lamotrigine (n = 118), carbamazepine (n = 83), valproate (n = 44) and levetiracetam (n = 27) being the four most common monotherapies. In the second birth, only risk of elective cesarean section (adjusted odds ratio 1.7, 95% confidence interval 1.4-2.0) and induction of labor (adjusted odds ratio 1.5, 95% confidence interval 1.2-1.7) were increased in women with epilepsy compared with women without epilepsy. There was a significant reduction in any hypertensive disorder, mild preeclampsia, emergency cesarean section, postpartum hemorrhage (>500 mL) and preterm birth from first to second birth in women with epilepsy, and also a significant increase in elective cesarean section. Conclusions. Second births in women with epilepsy do not represent an increased risk of non-iatrogenic complications, independent of antiepileptic drug use. There is a significant reduction in complications from first to second births in women with epilepsy.
Introduction
Epilepsy is the most common neurological disorder requiring continuous drug treatment during pregnancy, and 30-70% of pregnant women with epilepsy (WWE) use antiepileptic drugs (AEDs) (1) (2) (3) (4) . WWE, and WWE with AEDs in particular, have previously been described as high-risk parturients with an increased rate of obstetric
Key Message
Parity has a significant effect on risks of pregnancy and obstetric complications in women with epilepsy. Only the iatrogenic interventions elective cesarean section and induction of labor were increased in second births in a non-selected national cohort of women with epilepsy. Women with epilepsy follow a pattern similar to that of women without epilepsy with a reduced risk of pregnancy and obstetric complications from first to second birth. complications such as bleeding in pregnancy, hypertensive pregnancy disorders, induction of labor, cesarean section, postpartum hemorrhage and preterm delivery (5) (6) (7) (8) (9) . Guidelines and review articles have highlighted focused management and individual assessment for WWE in pregnancy to improve maternal morbidity and mortality (7, (10) (11) (12) . Complications in WWE imply possible consequences for the mother and her child and may affect reproductive intentions for some women (13, 14) . Pregnancy and obstetric complications increase risks for recurrence next time, and also affect risks for new complications in later pregnancies (13) (14) (15) (16) (17) (18) . Hence, subsequent pregnancies in the same woman are not independent events, and results from previous cross-sectional studies not taking this into account should be interpreted with caution.
Only two previous studies have examined first pregnancies separately for hypertensive complications in WWE (2, 19) . None have examined outcomes in second pregnancies, compared subsequent pregnancies, or assessed recurrence risks. Both the epilepsy and the use of AEDs are often persistent risk factors possibly influencing complications in later pregnancies and recurrence rates. Any difference in risk change from the first to the second pregnancy in WWE compared with women without epilepsy could elucidate mechanisms for complications in WWE, as recurrence risks can be used to explore etiological factors (20) .
Studies have focused on consequences of epilepsy and maternal AED use during pregnancy for fetal malformations and child development (21) (22) (23) (24) . In contrast, potential effects of epilepsy and specific AEDs on pregnancy have been much less studied. Optimal therapy in epilepsy represents a balance between seizure suppression and AED adverse effects. For women of fertile age, potential AED effects for the fetus as well as on the pregnancy should be of the highest relevance. It is necessary to estimate the specific effect of parity on complications in WWE with and without AEDs in order to give WWE optimal treatment and advice in preconceptional counseling.
Our aim was to estimate risks in first and second pregnancy and birth, and to estimate the effect of parity on changes in risks and recurrence rates for hypertensive pregnancy disorders, bleeding in pregnancy, induction of labor, cesarean section, postpartum hemorrhage and preterm delivery in WWE. The effect of AEDs in monotherapy was defined, and WWE were compared with women without epilepsy.
Material and methods
We used population-based data from the Medical Birth Registry of Norway (MBRN) during 1999-2013. A unique social security number given to all citizens in Norway enables linkage of data from various national data sources and all births to the same mother (sibship data). Linked data from the National Population Database ensure notification of all births and deaths in the country. Reporting to the MBRN is compulsory and data are prospectively registered throughout pregnancy, delivery and the postpartum period on a form that has remained unchanged since 1999. All data are forwarded to the MBRN by the attending midwife or obstetrician. Data include maternal and paternal social factors, maternal health before and during pregnancy, complications and interventions during pregnancy and birth, perinatal outcome, and complications in children.
First and second births were analyzed. Women with their first birth before the study period were excluded, as were birth orders higher than second. Women with a missing social security number (0.9%) were excluded. All births ≥22 weeks of gestation (singleton and multiple) were included.
The Norwegian Prescription Database (NorPD, commenced in 2004) provided detailed data on all medications dispensed from pharmacies by prescription. Mandatory registration in NorPD of every dispensed medical prescription is made by a pharmacist. Statistics Norway provided data on maternal level of education.
Exposure variables were a diagnosis of epilepsy at both births and the use of AEDs in both pregnancies. Maternal epilepsy was registered in a specific checkbox or by adding written text in a blank space available on the MBRN form. Information on type of epilepsy or seizure activity was not available. The epilepsy diagnosis in MBRN has previously been found to be valid in 92.3% of cases (3) . Information on AED use in pregnancy (identified by ATC classification) was recorded as written text with no information on dose or therapeutic changes over time. We analyzed total AED use and the four most common AEDs in monotherapy, this to obtain both homogeneous and large enough groups. Monotherapy was defined as using the same single AED in the first and second pregnancies. Linkage to NorPD enabled validation of the AED registration in the MBRN (data available [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] .
Main outcomes in the first and second births were: a compound variable of any hypertensive disorder in pregnancy, mild and severe preeclampsia, bleeding in pregnancy, induction of labor at term, emergency and elective cesarean section, postpartum hemorrhage (>500 mL and >1500 mL), and spontaneous preterm birth. Spontaneous preterm birth, <37 weeks (induction of labor and preterm elective cesarean sections were excluded from analyses) was calculated from ultrasound assessment of due date or last menstrual period (ultrasound dates were missing in 4251 women, 2.0% of births reported by health workers in the primary care or in hospital. Induction of labor included induction at term (37-41 weeks), regardless of method. Cesarean section was reported as an elective or emergency procedure. Bleeding during delivery and within the next 24 h after delivery (postpartum hemorrhage) was reported as >500 mL and >1500 mL. Other epilepsy core outcomes suggested by The CROWN initiative were either not properly addressed in the MBRN or severely underpowered for inclusion in our study (9) .
Other variables were: maternal age (≤19 years, 20-24 years, 25-29 years, 30-34 years, 35-39 years and ≥40 years), maternal education (≤10 years, 11-13 years, ≥14 years), chronic disease (kidney disease, hypertension, diabetes mellitus), multifetal pregnancies, high body mass index (BMI ≥ 30 kg/m 2 ), smoking during pregnancy, use of folic acid supplementation in standard dose (0.4 mg/day), interdelivery interval (inter-delivery interval: >6 years), augmented contractions in labor, vaginal operative delivery (vacuum or forceps), and placenta previa. BMI was available from 2006 onwards. Data on ethnicity and marital status were not available due to ethical restrictions.
Statistical analyses
All WWE were compared to all women without epilepsy. Risk of the various outcomes in first and second births were estimated by treatment category, i.e. WWE with and without AED, and by the four most common monotherapies. Changes in risks from first to second birth and recurrence rates were estimated in treatment categories. The recurrence rates in WWE and women without epilepsy were compared.
We estimated proportions and crude odds ratios (ORs) using contingency tables. Values of p were calculated by Fisher's exact test and independent sample t-tests, where appropriate. We used logistic regression to adjust for possible confounding by maternal age, educational level, multifetal pregnancy and chronic diseases (pre-existing hypertension, kidney disease and diabetes mellitus) for all outcomes. Furthermore adjustment by inter-delivery interval, induction of labor, placenta previa, cesarean section, augmented contractions, operative vaginal delivery and vaginal bleeding in pregnancy was made where appropriate. In addition, the effect of parity was evaluated with logistic regression interaction analyses. The covariates BMI (only registered since 2006) and smoking were restrained by missing cases and therefore studied with stratificationbased sensitivity analyses applied on all results and not included in the final logistic regression model. The impact of folic acid supplementation was similarly analyzed further with stratification-based sensitivity analyses. All analyses were performed with IBM SPSS (Statistical Package for Social Sciences) version 23.0 or later.
Ethical approval
The study was approved by the Regional Ethics Committee (REK 2013/186) and the Norwegian Data Protection Authority.
Results
During the study period, 361 588 women gave birth, of whom 211 248 had a second birth. There were 1074 (0.5%) women with registered epilepsy at both births. Maternal characteristics are presented in Table 1 . WWE had significantly longer inter-delivery interval, and significantly fewer had the same partner in the second birth compared with women without epilepsy. A second pregnancy was registered in 38.0% of WWE compared with 58.6% of women without epilepsy (p < 0.005). In all, 326 WWE used the same specified AED in monotherapy in both pregnancies, and the four most common drugs were lamotrigine (118 women), carbamazepine (83 women), valproate (44 women) and levetiracetam (27 women). The use of AED, AED polytherapy and treatment changes between the two births are reported in Table 2 .
All first births were analyzed separately (see Supporting Information, Table S1 ). We found increased risks of any hypertensive disorder, mild preeclampsia, induction of labor, all and elective cesarean section, bleeding in pregnancy, and preterm birth in WWE compared with women without epilepsy. First births of WWE who had a subsequent birth were compared with those with only one birth in the study period. WWE with only one birth had a significantly higher risk for preterm birth, but otherwise there were no significant differences.
In the second birth there was no increased risk for WWE when compared with women without epilepsy for the compound variable any hypertensive disorder, mild or severe preeclampsia, bleeding in pregnancy, emergency cesarean section, any postpartum hemorrhage, or preterm birth. The results were the same for all analyzed treatment categories of WWE; with and without AED, and for the four AED monotherapies (Table 3 and see Supporting  Information, Table S2 ). In the second birth there was an increased risk of elective cesarean section (aOR 1.7, 95% CI 1.4-2.0) and induction of labor (aOR 1.5, 95% CI 1.2-1.7) in WWE compared with women without epilepsy. The risk of elective cesarean section was similarly increased in WWE with AED (aOR 1.7, 95% CI 1. Prevalence of outcomes in WWE changed from the first to the second birth similar to the changes seen in women without epilepsy (Figure 1 ). When the first and second births of WWE were compared within treatment categories, the reduction in risk was significant for any hypertensive disorder, mild preeclampsia, emergency cesarean section and postpartum hemorrhage (>500 mL) in total WWE, WWE with and WWE without AEDs (Table 4) . For preterm birth and severe preeclampsia the reduction was significant in WWE and WWE without AED. The risk of elective cesarean section increased significantly from the first to the second birth in WWE, WWE with and without AED. All changes in outcome risks from the first to the second birth were significant also in women without epilepsy.
In WWE the recurrence rate of any hypertensive disorder was 21.4%, whereas the prevalence of any hypertensive disorder in the second birth without preceding occurrence was only 2.7%. Hence the risk of recurrence was highly significant (aOR 10.3, 95% CI 5.5-19.6) (see Supporting Information, Table S3 ). Similarly, the recurrence rate of all complications, except postpartum hemorrhage and severe preeclampsia, was significantly increased in WWE, WWE with and without AEDs. In women without epilepsy, the risk of recurrence was also significantly increased for all outcomes. When the risk of recurrent complications in WWE was compared with women without epilepsy, only induction of labor and elective cesarean section were increased for WWE (see Supporting Information, Table S4 ).
All estimates for second births were robust in sensitivity analyses including smoking, BMI > 30 kg/m 2 , and folic acid supplementation. Interaction analyses of epilepsy and parity did not show any significant interaction (results not shown). The analyses showed that parity had a higher impact than epilepsy as a predictor for all complications except preterm birth.
Antiepileptic drugs use as recorded in the MBRN, was validated by a corresponding prescription in NorPD during the pregnancy. The positive predictive values were: 
Discussion
Women with epilepsy have in their second pregnancy and birth no increased risk of any hypertensive disorder, mild or severe preeclampsia, vaginal bleeding in pregnancy, preterm birth, emergency cesarean section, or postpartum hemorrhage compared with women without epilepsy. This was true for WWE in general as well as for WWE on the most common AED monotherapies. This finding contrasts with previous studies, where increased pregnancy risks have been found for WWE (5) (6) (7) (8) . Our study shows that the increased risk occurs for the first, but not for the subsequent birth. This was confirmed by our observation of a significant risk reduction from the first to the second birth in WWE. This risk reduction in WWE showed a similar pattern as for women without epilepsy.
We found a significant impact of parity on complications in WWE in two dimensions; when compared with women without epilepsy and when comparing first and second births in WWE. The present study shows increased risks of complications in the first birth in WWE in line with previous results (5) (6) (7) (8) . In the second birth, complications occurred with the same frequency as in WWE without AED and in women without epilepsy. As WWE had a risk change similar to that of women without epilepsy from first to second birth, non-epilepsy factors are important for risk development in WWE. Figure 1 . Prevalence of complications in first and second births for women with and without epilepsy. Prevalence (%) of complications in 361 588 first births and 211 248 consecutive second births from the same women. Complications are defined in women with epilepsy (WWE), WWE with and without antiepileptic drugs (AEDs), and women without epilepsy. Statistics and comparisons in the first births, the second births, and changes from the first to the second births are also shown in the Supporting Information (Table S1), Tables 3 and 4 , respectively. [Color figure can be viewed at wileyonlinelibrary.com]. Table 4 . Change in prevalence from first to second birth in women with epilepsy (WWE) with and without antiepileptic drugs (AEDs). The risk of elective cesarean section and induction of labor in WWE both with and without AEDs remained increased for the second birth, and the risk of recurrence was increased compared with women without epilepsy. Elective cesarean section and induction of labor are both interventions decided by physicians, with consent from the patient, with the aim to end the pregnancy before or without natural labor. Epilepsy or AED use in itself should not be regarded as indications for either elective cesarean section or induction of labor (11, 25) . Previously, the background for increased cesarean section and induction of labor in WWE has been thought to be multifactorial and mediated by fetal conditions, maternal conditions and the diagnosis of epilepsy (4, 5) . As there were no increased complications in second pregnancies; and no change in use of AED, this was probably not the reason for the increase in elective cesarean section or induction of labor. Although most WWE remain seizure free in pregnancy, the progressing pregnancy can result in increased physical or mental stress (26) . Lowered seizure threshold or adverse outcomes are feared consequences in WWE. The increased rates of elective cesarean section and induction of labor in the second birth most likely represent preventive measures directly linked to the diagnosis of epilepsy, as convenience is rarely an indication for elective cesarean section in Norway and trial of labor after previous cesarean section is readily recommended and practiced accordingly (11, 16) . Events and indications for delivery in first pregnancy impact on mode of delivery in subsequent births (13) . This could explain some of the increased risk of elective cesarean section seen in subsequent pregnancies both in WWE and women without epilepsy.
This study represents a selected epilepsy population as the included women have given birth at least twice, thereby possibly excluding those with severe complications and severe cases of epilepsy in women who would choose not to repeat a pregnancy. Seizure frequency, lifestyle, or socioeconomic status that encourages subsequent pregnancies in WWE is expected to affect risks also in the second pregnancy. However, background data for WWE with subsequent births in this study did not differ from the same nullipara population, with the exception of less obesity in women who had a second birth. Major complications among WWE with only one birth did not differ from WWE with subsequent pregnancies. Hence it is not likely that obstetric complications have been a reason for ending reproduction in WWE. Seizure activity and adverse fetal outcomes can possibly influence a choice of further reproduction in WWE. Our study was not able to examine such associations.
Our large and unselected nationwide cohort enabled assessment of complications in first and second birth separately, and risks associated with the most common AEDs in monotherapy. The sibship structure of our data enabled us to account for the obvious dependence between two births from the same woman. The standardized data collection provided information of high validity (3) . The study population had a diagnosis of epilepsy with proven high validity in both the first and second births. The separate recordings confirm more definitely the epilepsy diagnosis, particularly relevant in WWE without AEDs, and to a greater extent exclude women with non-epileptic seizures. Linkage to NorPD confirmed the high validity of AED registration in the MBRN.
The MBRN does not register seizure activity or type of epilepsy, this being a limitation of our study. However, a previous study did not find any association between seizure activity and complications in pregnancy (3). WWE with specified AED monotherapy had low frequencies of most complications, and therefore our study lacks strength for several variables despite our large cohort of pregnant women. We lacked information on ethnicity and marital status, which were not released due to ethical considerations.
We found a significant reduction in risk of pregnancy and obstetric complications from first to second pregnancy in WWE. Second pregnancies in WWE did not have any increased risk of complications. Only the iatrogenic interventions, induction of labor and elective cesarean section were increased in second births. These interventions also had an increased risk of recurrence in WWE compared with women without epilepsy. This suggests that the epilepsy alone is not the reason for the increase in complications seen in first pregnancies in WWE, as the epilepsy and AED treatment remained unchanged from first to second pregnancy. The reduction of complications was also seen in women without epilepsy. However, the reduction of complications in WWE was so pronounced that there was no longer any difference between WWE and women without epilepsy at the second pregnancy and birth. The reduction in obstetric complications, to the level seen in women without epilepsy, is important and should be considered in all individual risk assessments and counseling of WWE.
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